1-12 of 12
Jeremy T. Larsen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination

Saurabh Zanwar, Matthew Ho, Francis K. Buadi, Sikander Ailawadhi, Jeremy T. Larsen, P. Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A. Gertz, Wilson I. Gonsalves, Ronald Go, Suzanne R. Hayman, Prashant Kapoor, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma M Warsame, Amie Fonder, Miriam A. Hobbs, Yi L. Hwa, Robert A. Kyle, S. Vincent Rajkumar, Shaji K Kumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 10017–10019.
https://doi.org/10.1182/blood-2022-167181
Published: 2022
Journal Articles

Electrocardiogram As a Marker of Cardiac Response in Light Chain Amyloidosis

Rodrigo Fonseca, Yael Kusne, Mariano Arribas, Molly Klanderman, Julia E. Wiedmeier, Eli Muchtar, P. Leif Bergsagel, Craig B. Reeder, Jeremy T. Larsen, Rafael Fonseca, Julie L Rosenthal
Journal: Blood
Blood (2022) 140 (Supplement 1): 12566–12567.
https://doi.org/10.1182/blood-2022-168083
Published: 2022
Journal Articles

Prognostic Value of Month 1 Bone Marrow and PET MRD Status in CAR-T Therapy for Myeloma

Radhika Bansal, Sikander Ailawadhi, Jeremy T. Larsen, Morie A Gertz, Matthew A. Hathcock, David Dingli, Prashant Kapoor, Taxiarchis Kourelis, Suzanne R. Hayman, Rahma M Warsame, Moritz Binder, Ricardo D Parrondo, Rafael Fonseca, P. Leif Bergsagel, Shaji K Kumar, Yi Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 1862–1864.
https://doi.org/10.1182/blood-2022-166662
Published: 2022
Journal Articles

Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis

Ricardo D Parrondo, Lindsay Brooke Gardner, Mohamad Alhaj Moustafa, Vivek Roy, Taimur Sher, Ahsan Rasheed, Rahma M Warsame, Jeremy T. Larsen, Wilson I. Gonsalves, Taxiarchis Kourelis, Prashant Kapoor, Rafael Fonseca, Asher Chanan-Khan, Sikander Ailawadhi
Journal: Blood
Blood (2022) 140 (Supplement 1): 7237–7238.
https://doi.org/10.1182/blood-2022-169533
Published: 2022
Journal Articles

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) +/- Daratumumab Treatment Results in Sustained Hematologic Response in Patients with AL Amyloidosis: A Retrospective Analysis of Patients at Mayo Clinic

Yael Kusne, Rodrigo Fonseca, Mariano Arribas, Molly Klanderman, Julia E. Wiedmeier, Craig B. Reeder, Jeremy T. Larsen, P. Leif Bergsagel, Julie L Rosenthal, Rafael Fonseca
Journal: Blood
Blood (2022) 140 (Supplement 1): 7224–7225.
https://doi.org/10.1182/blood-2022-166668
Published: 2022
Journal Articles

Ocular Toxicity of Commercially Available Belantamab Mafodotin in Patients with Advanced Multiple Myeloma

Jithma P. Abeykoon, Luliana Vaxman, Sanjay V Patel, Shaji Kumar, Kimberly S Young, Sikander Ailawadhi, Jeremy T. Larsen, Wilson I Gonsalves, Taxiarchis Kourelis, Nelson Leung, Rahma M Warsame, Miriam A. Hobbs, Amie Fonder, Yi L. Hwa, P. Leif Bergsagel, Martha Q. Lacy, S. Vincent Rajkumar, Morie A. Gertz, Prashant Kapoor
Journal: Blood
Blood (2021) 138 (Supplement 1): 2711.
https://doi.org/10.1182/blood-2021-154183
Published: 2021
Journal Articles

Iberdomide (IBER) in Combination with Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Dose-Expansion Phase of the CC-220-MM-001 Trial

Sagar Lonial, Rakesh Popat, Cyrille Hulin, Sundar Jagannath, Albert Oriol, Paul G. Richardson, Thierry Facon, Katja Weisel, Jeremy T. Larsen, Monique C. Minnema, Al-Ola Abdallah, Ashraf Z. Badros, Stefan Knop, Edward A. Stadtmauer, Min Chen, Tuong Vi Nguyen, Alpesh Amin, Elisabeth Kueenburg, Teresa Peluso, Niels W.C.J. van de Donk
Journal: Blood
Blood (2021) 138 (Supplement 1): 162.
https://doi.org/10.1182/blood-2021-147704
Published: 2021
Journal Articles

Phase 1b/2 Study of the First-in-Class SUMO-Activating Enzyme Inhibitor TAK-981 in Combination with Monoclonal Antibodies in Patients with Triple-Class Refractory Multiple Myeloma

Sagar Lonial, Stefano R. Tarantolo, Ralph V. Boccia, Habte Yimer, Moshe Y. Levy, Rafat Abonour, Meera Mohan, Vivek Roy, Jeremy T. Larsen, Saulius K. Girnius, Cara A. Rosenbaum, Omar Nadeem, Deborah Berg, Bo Chao, Allison J Berger, Akito Nakamura, Yuhong Zhang, Keli Song, Christine K. Ward, Igor Proscurshim, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 2742.
https://doi.org/10.1182/blood-2021-148385
Published: 2021
Journal Articles

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

Julia E. Wiedmeier, Madiha Iqbal, Javier Munoz, Evandro D. Bezerra, Juan Esteban Garcia Robledo, Radhika Bansal, Patrick B. Johnston, Matthew Hathcock, Jeremy T. Larsen, P. Leif Bergsagel, Yucai Wang, Craig B. Reeder, Jose F. Leis, Rafael Fonseca, Jeanne M. Palmer, Rahma M Warsame, Taxiarchis Kourelis, Suzanne R. Hayman, David Dingli, Prashant Kapoor, Shaji Kumar, Urshila Durani, Jose C. Villasboas, Jonas Paludo, N. Nora Bennani, Stephen M. Ansell, Januario E Castro, Mohamed A. Kharfan-Dabaja, Yi Lin, Paschalis Vergidis, Hemant S. Murthy, Allison C. Rosenthal
Journal: Blood
Blood (2021) 138 (Supplement 1): 1750.
https://doi.org/10.1182/blood-2021-151859
Published: 2021
Journal Articles

Serum Free Light Chain Ratio in Distinguishing Smoldering Multiple Myeloma From Active Multiple Myeloma,

Jeremy T Larsen, MD, Shaji Kumar, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2011) 118 (21): 3948.
https://doi.org/10.1182/blood.V118.21.3948.3948
Published: 2011
Journal Articles

Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival

Clinical Trials & Observations
Jeremy T. Larsen, Cheng E. Chee, John A. Lust, Philip R. Greipp, S. Vincent Rajkumar
Journal: Blood
Blood (2011) 118 (10): 2702–2707.
https://doi.org/10.1182/blood-2011-03-341933
Published: 2011
Journal Articles

Reduction In Proliferative Rate of Myeloma Plasma Cells Measured by the Plasma Cell Labeling Index Predicts Improved Survival In Multiple Myeloma

Jeremy T Larsen, MD, Cheng E. Chee, MD, John Lust, MD, PhD, Philip R. Greipp, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2010) 116 (21): 4048.
https://doi.org/10.1182/blood.V116.21.4048.4048
Published: 2010